Teleflex Incorporated Teleflex Incorporated

Teleflex Incorporated

TFX

Rangering i aksjer #3211
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Aksjekurs
$130.16
Sist synkronisert: 2026-10-16
Markedsverdi
$5.52B
Endring (1 dag)
1.43%
Endring (1 år)
1.58%
Land
US
Handel Teleflex Incorporated (TFX)

Kategori

Healthcare
Driftsmargin for Teleflex Incorporated (TFX)
Driftsmargin per October 2026 TTM: 3.35%
Ifølge Teleflex Incorporated sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 3.35%. Ved slutten av 2023 hadde selskapet en driftsmargin på 17.02%.
Historikk for driftsmargin for Teleflex Incorporated fra 2000 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
2026 (TTM) 3.35% -32.46%
2024 4.96% -70.86%
2023 17.02% -4.92%
2022 17.90% -19.95%
2021 22.36% 34.13%
2020 16.67% 1.28%
2019 16.46% 25.27%
2018 13.14% -24.27%
2017 17.35% 1.46%
2016 17.10% -2.06%
2015 17.46% 12.79%
2014 15.48% 12.58%
2013 13.75% -318.95%
2012 -6.28% -141.18%
2011 15.25% 0.39%
2010 15.19% 6.45%
2009 14.27% 1.64%
2008 14.04% 40.96%
2007 9.96% 3.53%
2006 9.62% -2.53%
2005 9.87% 75.94%
2004 5.61% -93.92%
2003 92.21% 827.67%
2002 9.94% 0.61%
2001 9.88% -2.56%
2000 10.14% 0.00%
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
31.28% -90.66%
US
12.36% -96.31%
FR
0.00% -
JP
9.83% -97.07%
US
0.00% -
CH
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.